Inactivation of the antibacterial and cytotoxic properties of silver ions by biologically relevant compounds

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Mulley, Geraldine ^a   Jenkins, A Tobias A ^b   Waterfield, Nicholas R ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b University of Bath   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLUTATHIONE; SILVER NITRATE; THIOL; ANTIINFECTIVE AGENT; BIOMATERIAL; ION; SILVER; THIOL DERIVATIVE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG INACTIVATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; LIMIT OF QUANTITATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; BANDAGE; CELL CULTURE; CELL DEATH; CELL NUCLEUS; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST;

ADULT; ANTI-BACTERIAL AGENTS; BANDAGES; CELL DEATH; CELL NUCLEUS; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CYSTEINE; FIBROBLASTS; GLUTATHIONE; HUMANS; IONS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SILVER; SILVER NITRATE; STAPHYLOCOCCUS AUREUS; SULFHYDRYL COMPOUNDS;

EID: 84899632703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094409     Document Type: Article

References (45)

1. Bayston R, Vera L, Mills A, Ashraf W, Stevenson O, et al. (2010) In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J Antimicrob Chemother 65: 258-265.
2. Beam JW (2009) Topical silver for infected wounds. J Athl Training 44: 531-533.
3. Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40: 257-262. (Pubitemid 28552392)
4. Duran N, Marcato PD, De Conti R, Alves OL, Costa FTM, et al. (2010) Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 21: 949-959.
5. Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27: 76-83.
6. Samberg ME, Orndorff PE, Monteiro-Riviere NA (2011) Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 5: 244-253.
7. Burrell RE (2003) A scientific perspective on the use of topical silver preparations. Ostomy Wound Manag 49.
8. Lansdown ABG (2010) Silver in healthcare; Anderson, D, Waters, M.D., Marrs, T.C., editor. Cambridge: Royal Society of Chemistry.
9. Gallant-Behm CL, Yin HQ, Liu SJ, Heggers JP, Langford RE, et al. (2005) Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen 13: 412-421. (Pubitemid 41060423)
10. Greulich C, Braun D, Peetsch A, Diendorf J, Siebers B, et al. (2012) The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range. RSC Adv 2: 6981-6987.
11. Toy LW, Macera L (2011) Evidence-based review of silver dressing use on chronic wounds. J Am Acad Nurse Prac 23: 183-192.
12. Hidalgo E, Dom?́nguez C (1998) Study of cytotoxicity mechanisms of silver nitrate in human dermal fibroblasts. Toxicol Lett 98: 169-179. (Pubitemid 28403581)
13. Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD (1997) Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol 25: 279-283. (Pubitemid 27438351)
14. Gordon O, Vig Slenters T, Brunetto PS, Villaruz AE, Sturdevant DE, et al. (2010) Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 54: 4208-4218.
15. Grade S, Eberhard J, Neumeister A, Wagener P, Winkel A, et al. (2012) Serum albumin reduces the antibacterial and cytotoxic effects of hydrogel-embedded colloidal silver nanoparticles. RSC Adv 2: 7190-7196.
16. Stewart EJ, Aslund F, Beckwith J (1998) Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins. EMBO J 17: 5543-5550. (Pubitemid 28445966)
17. Smirnova GV, Oktyabrsky ON (2005) Glutathione in bacteria. Biochemistry (Mosc) 70: 1199-1211. (Pubitemid 41802114)
18. Wu G, Fang Y-Z, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489-492. (Pubitemid 38298485)
19. Fahey RC (2001) Novel thiols of Prokaryotes. Annu Rev Microbiol 55: 333-356. (Pubitemid 32978109)
20. Gaballa A, Newton GL, Antelmann H, Parsonage D, Upton H, et al. (2010) Biosynthesis and functions of bacillithiol, a major low-molecular-weight thiol in Bacilli. Proc Natl Acad Sci USA 107: 6482-6486.
21. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
22. Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, et al. (2004) Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 101: 9786-9791. (Pubitemid 38869314)
23. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
24. Iwasaki Y, Saito Y, Nakano Y, Mochizuki K, Sakata O, et al. (2009) Chromatographic and mass spectrometric analysis of glutathione in biological samples. J Chromatogr B 877: 3309-3317.
25. Richie JP, Skowronski L, Abraham P, Leutzinger Y (1996) Blood glutathione concentrations in a large-scale human study. Clin Chem 42: 64-70. (Pubitemid 26030383)
26. Xiu Z-m, Zhang Q-b, Puppala HL, Colvin VL, Alvarez PJJ (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12: 4271-4275.
27. Yang X, Gondikas AP, Marinakos SM, Auffan M, Liu J, et al. (2011) Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. Environ Sci Technol 46: 1119-1127.
28. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA (2007) Effect of silver on burn wound infection control and healing: Review of the literature. Burns 33: 139-148. (Pubitemid 46188672)
29. McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, et al. (1989) In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res 46: 267-274. (Pubitemid 19098339)
30. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H (2010) Topical silver for preventing wound infection. Cochrane Db Syst Rev 3.
31. Li X, Nikaido H, Williams K (1997) Silver-resistant mutants of Escherichia coli display active efflux of Ag + and are deficient in porins. J Bacteriol 179: 6127-6132. (Pubitemid 27419039)
32. Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27: 341-353. (Pubitemid 36694661)
33. Slawson RM, Van Dyke MI, Lee H, Trevors JT (1992) Germanium and silver resistance, accumulation, and toxicity in microorganisms. Plasmid 27: 72-79.
34. Gupta A, Matsui K, Lo J-F, Silver S (1999) Molecular basis for resistance to silver cations in Salmonella. Nat Med 5: 183-188. (Pubitemid 29068525)
35. Park H-J, Kim JY, Kim J, Lee J-H, Hahn J-S, et al. (2009) Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res 43: 1027-1032.
36. Cortese-Krott MM, Munchow M, Pirev E, Hessner F, Bozkurt A, et al. (2009) Silver ions induce oxidative stress and intracellular zinc release in human skin fibroblasts. Free Radical Bio Med 47: 1570-1577.
37. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, et al. (2011) Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201: 92-100.
38. Yoshimaru T, Suzuki Y, Inoue T, Niide O, Ra C (2006) Silver activates mast cells through reactive oxygen species production and a thiol-sensitive storeindependent Ca2+ influx. Free Radical Bio Med 40: 1949-1959. (Pubitemid 43728862)
39. Babula P, Masarik M, Adam V, Eckschlager T, Stiborova M, et al. (2012) Mammalian metallothioneins: properties and functions. Metallomics 4: 739-750.
40. Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, et al. (2013) The role of metallothionein in oxidative stress. Int J Mol Sci 14: 6044-6066.
41. Luther EM, Schmidt MM, Diendorf J, Epple M, Dringen R (2012) Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles. Neurochem Res 37: 1639-1648.
42. Miyayama T, Arai Y, Suzuki N, Hirano S (2013) Mitochondrial electron transport is inhibited by disappearance of metallothionein in human bronchial epithelial cells following exposure to silver nitrate. Toxicology 305: 20-29.
43. Xu FF, Imlay JA (2012) Silver(I), Mercury(II), Cadmium(II), and Zinc(II) Target Exposed Enzymic Iron-Sulfur Clusters when They Toxify Escherichia coli. Appl Environ Microbiol 78: 3614-3621.
44. Hwang I-S, Lee J, Hwang JH, Kim K-J, Lee DG (2012) Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J 279: 1327-1338.
45. Teodoro JS, Simões AM, Duarte FV, Rolo AP, Murdoch RC, et al. (2011) Assessment of the toxicity of silver nanoparticles in vitro: A mitochondrial perspective. Toxicol in Vitro 25: 664-670.